CLASS III Drug recall · Reported 27 May 2015 · FDA Enforcement Report

ImproVue Ophthalmic Lubricant Drops recalled by Oasis Medical

Oasis Medical is recalling ImproVue Ophthalmic Lubricant Drops (1.7% Hypromellose) Use Syringe Use Applicator Tip per, distributed in Florida. The recall was initiated on 10 Apr 2015 and the FDA has classified it as Class III.

Check your package

Lot, batch or date codesLot# V0814B, Exp 02/16; V1014H, Exp 04/16
Quantity recalled9,731 cartons

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-1084-2015
FDA event ID
71152
Recalling firm
Oasis Medical, Glendora, CA
Classification
Class III
Status
Terminated
Recall initiated
10 Apr 2015
FDA classified
21 May 2015
Reported
27 May 2015
Type
Voluntary: Firm initiated
Customers notified by
Telephone
Reason category
Other Reasons
Drug class
Eye Drops

Timeline

10 Apr 2015Recall initiated by company
21 May 2015Classified by FDA+41 days
27 May 2015Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Failed pH specification

Product as listed by the FDA

ImproVue Ophthalmic Lubricant Drops (1.7% Hypromellose), 1 Single Use Syringe, 0.07 fl oz (2mL), 1 Single Use Applicator Tip per carton, Manufactured for OCULUS SURGICAL, Port St. Lucie, FL 34986, NDC 62144-5510-05

Where it was distributed

FL

Florida

Questions about this recall

Why was it recalled?

Failed pH specification

Which lots are affected?

Lot# V0814B, Exp 02/16; V1014H, Exp 04/16

Where was it sold?

FL

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class III mean?

Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Oasis Medical

All 7